HK2 and cancer: This miRNA downregulated expression of glycolytic enzyme Hexokinase 2 (HK2), which gene is frequently overexpressed in malignant tumors by mammalian target of rapamycin activation, decreases glucose metabolism, prevents cancer cell development, and inhibits tumor development over targeting HK2 [98].